Peloton Therapeutics

Merck Co headquarters

Pharma

FDA signs off on 2nd approval for Merck's Welireg

Merck has gained its second FDA approval for Welireg, which is now endorsed to treat late-stage renal cell carcinoma.

Kevin Dunleavy Dec 15, 2023 11:33am

Kidney cancer

At ESMO, Merck touts Welireg's potential in kidney cancer

Oct 21, 2023 9:00am